Hypertension and Renal Function in Diabetes Mellitus—A Review

References

• Jarrett R J, Keen H, McCartney M, Fuller J H, Hamilton P JS, Reid D D, Rose G. Glucose tolerance and blood pressure in two population samples: Their relation to diabetes mellitus and hypertension. Int J Epidemiol 1978; 7: 15–24
   PubMed Web of Science ®Google Scholar
• Pell S, D'Alonzo C A. Some aspects of hypertension in diabetes mellitus. J Am Med Assoc 1967; 202: 104–110
   PubMed Web of Science ®Google Scholar
• Viberti G C, Wiseman M J, Bending J J. Prevention of diabetic nephropathy: Markers of disease and perspectives for intervention. Diabetic Med 1986; 3: 208–211
   PubMedGoogle Scholar
• Christlieb A R, Warran J H, Krolewski A S, Busick E J, Ganda O MP, Asmal A C, Soeldner J S, Bradley R F. The major risk in juvenile-onset insulin-dependent diabetes. Diabetes 1981; 30(Suppl. 2)90–96
   PubMedGoogle Scholar
• Feldt-Rasmussen B, Borsch-Johnsen K, Mathiesen E R. Hypertension in diabetes as related to nephropathy. Early blood pressure changes. Hypertension 1985; 7(Suppl. 2)18–20
   Google Scholar
• O'Hare J A, Ferris J B, Twomey B, O'Sullivan D J. Poor metabolic control, hypertension and microangiopathy independently increase the transcapillary escape rate of albumin in diabetes. Diabetiologia 1983; 25: 260–263
   PubMedGoogle Scholar
• Parving H H, Noer I, Deckert T, Evrin P E, Nielsen S L, Lyngsoe J, Mogensen C E, Rorth M, Svendsen P A, Traf-Jensen J, Lassen N A. The effect of metabolic regulation in microvascular permeability to small an large molecules in short-term juvenile diabetics. Diabetologia 1976; 12: 161–166
   PubMedGoogle Scholar
• Parving H H, Kastrup J, Smidt U M. Reduced transcapillary escape of albumin during acute blood pressure-lowering in type I (insulin dependent) diabetic patients with nephropathy. Diabetologia 1985; 28: 797–801
   PubMed Web of Science ®Google Scholar
• Mogensen C E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685–688
   PubMed Web of Science ®Google Scholar
• Parving H H, Andersen A R, Smidt U M, Svendsen P A. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; 1: 1175–1178
   PubMed Web of Science ®Google Scholar
• Ditscherlein G. Renal histopatholgy in hypertensive diabetic patients. Hypertension 1985; 7(Suppl II)29–32
   Google Scholar
• Mauer S M, Steffes M W, Azar S, Sandberg S K, Bruns D M. The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes 1978; 27: 738–744
   PubMed Web of Science ®Google Scholar
• Chiappe De Cingolani G E. Cyclic AMP and glucose utilization by diabetic rat fat cells. Arch Int Physiol Biochem 1983; 91: 1–8
   PubMedGoogle Scholar
• Chiappe De Cingolani G E. Beta-adrenergic receptors and adenylate cyclase activity in diabetic rat fat cell. Diabetes 1986; 35: 1229–1232
   PubMedGoogle Scholar
• Weidmann P, Beretta-Picoli C, Trost B N. Pressor factors and responsivenss in hypertension accompanying diabetes mellitus. Hypertension 1985; 7(Suppl. II)33–42
   Google Scholar
• Weidmann P, Beretta-Picoli C, Keusch G, Glueck Z, Mujagic M, Meier A, Ziegler W H. Sodium-volume factor, cardiovascular reactivity and hypotensive mechanisms of diuretic therapy in hypertension associated with diabetes mellitus. Am J Med 1979; 67: 779–784
   PubMed Web of Science ®Google Scholar
• Zats R, Meyer T W, Rennke H G, Brenner B M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci (USA) 1985; 82: 5963–5967
   PubMedGoogle Scholar
• Bunn H F, Cahill J. Glycosylated hemoglobin: Their role in the control and complications of diabetes. Harrison's Principles of Internal Medicine. Update I, K. J. Isselbacher, R. D. Adams, E. Braunwald, J. B. Martin, R. G. Petersdorf, J. D. Wilson. McGraw-Hill, New York 1981; 33–41
   Google Scholar
• Fuller J H, Elford J, Goldblatt P, Adelstein A M. Diabetes mortality: New light on an under-estimated health problem. Diabetologica 1983; 24: 336–341
   PubMedGoogle Scholar
• West K M. Epidemiology of Diabetes and Its Vascular Lesions. Elsevier, New York 1978; 368–378
   Google Scholar
• Duprees E A, Meyer M B. Role of risk factors in complications of diabetes mellitus. Am J Epidemiol 1980; 112: 100–112
   PubMedGoogle Scholar
• Klein R, Klein E, Syrijala B, Davis M D, Meuer M M, Magli Y. Wisconsin epidemiologic study of diabetic nephropathy. Diabetic renal-retinal syndrome II, E A Friedman, F A L'Esperance. Grune & Stratton. 1981; 41
   Google Scholar
• Knowler W C, Bennett P H, Ballintine E J. Increased incidence of retinopathy in diabetics with elevated blood pressure. N Engl J Med 1980; 302: 645–650
   PubMed Web of Science ®Google Scholar
• Bodansky H J, Cudworth A G, Drury P L, Kohner E M. Risk factors associated with severe proliferative retinopathy in Type I (insulin dependent) diabetes. Diabetes Care 1982; 5: 97–100
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Mathiesen E, Deckert T. Effect in the progression of diabetic renal disease during two years of strict metabolic control in insulin dependent diabetes. Abstract. Diabetes. 1987; 8107A: 35, (Suppl. 1)
   Google Scholar
• Mogensen C E. Hypertension in diabetes and the stage of diabetic nephropathy. Editorial Review. Diabetic Nephropathy 1982; 1: 2–7
   Google Scholar
• Cohen D, Herzog D, Serban I, Gavendo S, Kapular S, Eliahou H E (1987) The calcium-ion blocker nisoldipine decreased the rate of progression of chronic renal failure in man, without correlating with change in blood pressure. Abstract. 24th European Dialysis and Transplant Association Meeting. October 25–29, 1987. West Berlin
   Google Scholar
• Goligorsky M S, Chaimovitz C, Rapoport J, Goldstein J, Kol R. Calcium metabolism in uremic nephrocalcinosis: Preventive effect of verapamil. Kidney Int 1985; 27: 774–779
   PubMed Web of Science ®Google Scholar
• Harris D CH, Hammond W S, Burke T J, Schrier R W. Verapamil protects against progression of experimental chronic renal failure. Kidney Int 1987; 31: 41–46
   PubMed Web of Science ®Google Scholar
• Gimenez L F, Solez K, Gordon Walker W. Relation between renal calcium content and renal impairment in 246 human renal biopsies. Kidney Int 1987; 31: 93–99
   PubMedGoogle Scholar
• Pelyo J C, Harris C H, Schrier R W. Effect of verapamil on glomerular hemodynamics in rats with partial nephrectomy. Abstract. Kidney Int 1987; 31: 391
   Google Scholar
• Mitch W E, Walser M, Steinman T I, Hill S, Zeger S, Tungsanga K. The effect of a keto acid-amino acid supplement to a restricted diet in the progression of chronic renal failure. N Engl J Med 1984; 311: 623–629
   PubMedGoogle Scholar
• Ferris J B, O'Hare J A, Kellehere C CM, Sullivan P A, Cole M M, Ross H F, O'Sullivan D J. Diabetic control and the renin-angiotensin system, catecholamines and blood pressure. Hypertension 1985; 2(Suppl)58–63
   Google Scholar
• Struthers A D. The choice of antihypertensive therapy in the diabetic. Postgrd Med J 1985; 61: 563–569
   PubMedGoogle Scholar
• Barnett A H, Leslie D, Watkins P J. Can insulin treated diabetics be given beta-adrenergic blocking drugs?. Br Med J 1980; 280: 976–978
   PubMedGoogle Scholar
• Waal-Manning H J. Can beta-blockers be used in diabetics patients?. Drugs 1979; 17: 157–160
   PubMedGoogle Scholar
• Anderson S, Meyer T, Rennke H G, Brenner B M. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 1985; 76: 612–619
   PubMed Web of Science ®Google Scholar
• Hommel E, Parving H H, Mathiesen E, Edsberg B, Nielsen D M, Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986; 793: 467–470
   Google Scholar
• Bjorck S, Nyberg G, Mulec H, Granerus G, Herlitz H, Aurell M. Beneficial effects of angiotensin converting enzyme inhibition on renal function in patients with diabetic nephropathy. Br Med J 1986; 293: 471–474
   PubMed Web of Science ®Google Scholar